Simultaneous determination of nine model compounds in permeability samples using RP-HPLC: Application to prove the cassette administration principle in single pass intestinal perfusion study in rats

Journal of Pharmaceutical and Biomedical Analysis

Volumn 67-68, Issue , 2012, Pages 71-76

  Wahajuddin, ^a,b   Singh, Sheelendra Pratap ^a   Raju, K S R ^a   Nafis, Asad ^b   Jain, Girish Kumar ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b National Institute of Pharmaceutical Education and Research (NIPER)   (India)

Author keywords

Intestinal permeability; Phenol red; Rat; RP HPLC; Single pass intestinal perfusion

Indexed keywords

ATENOLOL; CAFFEINE; CEFALEXIN; HYDROCHLOROTHIAZIDE; KETOPROFEN; METOPROLOL; PARACETAMOL; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG PENETRATION; DRUG STABILITY; EXPERIMENTAL MODEL; HIGH THROUGHPUT SCREENING; INTESTINE MUCOSA PERMEABILITY; INTESTINE PERFUSION; JEJUNUM; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; INTESTINES; LIMIT OF DETECTION; MODELS, THEORETICAL; PERMEABILITY; RATS; REPRODUCIBILITY OF RESULTS;

EID: 84862139363     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.03.048     Document Type: Article

References (22)

1. Venkatesh G., Ramanathan S., Mansor S.M., Nair N.K., Sattar M.A., Croft S.L., Navaratnam V. Development and validation of RP-HPLC-UV method for simultaneous determination of buparvaquone, atenolol, propranolol, quinidine and verapamil: a tool for the standardization of rat in situ intestinal permeability studies. J. Pharm. Biomed. Anal. 2007, 43:1546-1551.
2. Barthe L., Woodley J., Houin G. Gastrointestinal absorption of drugs: methods and studies. Fundam. Clin. Pharmacol. 1999, 13:154-168.
3. Acra S.A., Ghishan F.K. Methods of investigating intestinal transport. JPEN J. Parenter. Enteral Nutr. 1991, 15:93S-98S.
4. Salphati L., Childers K., Pan L., Tsutsui K., Takahashi L. Evaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in man. J. Pharm. Pharmacol. 2001, 53:1007-1013.
5. Guidance for Industry Waiver of In Vivo Biovailability and Bioequivalence Studies for Immediate-Release Solid Dosage Forms Based on a Biopharmaceutics Classification System 2000, CDER/FDA.
6. Chawla S., Ghosh S., Sihorkar V., Nellore R., Kumar T.R., Srinivas N.R. High-performance liquid chromatography method development and validation for simultaneous determination of five model compounds, antipyrine, metoprolol, ketoprofen, furosemide and phenol red, as a tool for the standardization of rat in situ intestinal permeability studies using timed wavelength detection. Biomed. Chromatogr. 2006, 20:349-357.
7. Patil A., Raheja V., Damre A. Simultaneous analysis of intestinal permeability markers, caffeine, paracetamol and sulfasalazine by reverse phase liquid chromatography: a tool for the standardization of rat everted gut sac model. Asian J. Pharm. Clin. Res. 2010, 3:204-207.
8. Varma M.V., Sarkar M., Kapoor N., Panchagnula R. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs. 1. Simultaneous determination of quinidine and permeability markers in rat in situ perfusion samples. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2005, 816:243-249.
9. Issa C., Gupta P., Bansal A.K. Implications of density correction in gravimetric method for water flux determination using rat single-pass intestinal perfusion technique: a technical note. AAPS PharmSciTech 2003, 4:E16.
10. Zakeri-Milani P., Valizadeh H., Tajerzadeh H., Azarmi Y., Islambolchilar Z., Barzegar S., Barzegar-Jalali M. Predicting human intestinal permeability using single-pass intestinal perfusion in rat. J. Pharm. Sci. 2007, 10:368-379.
11. Bansal T., Singh M., Mishra G., Talegaonkar S., Khar R.K., Jaggi M., Mukherjee R. Concurrent determination of topotecan and model permeability markers (atenolol, antipyrine, propranolol and furosemide) by reversed phase liquid chromatography: utility in Caco-2 intestinal absorption studies. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2007, 859:261-266.
12. Crowe A., Lemaire M. In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin. Pharm. Res. 1998, 15:1666-1672.
13. Fagerholm U., Johansson M., Lennernas H. Comparison between permeability coefficients in rat and human jejunum. Pharm. Res. 1996, 13:1336-1342.
14. Fagerholm U., Nilsson D., Knutson L., Lennernas H. Jejunal permeability in humans in vivo and rats in situ: investigation of molecular size selectivity and solvent drag. Acta Physiol. Scand. 1999, 165:315-324.
15. Kim J.S., Mitchell S., Kijek P., Tsume Y., Hilfinger J., Amidon G.L. The suitability of an in situ perfusion model for permeability determinations: utility for BCS class I biowaiver requests. Mol. Pharm. 2006, 3:686-694.
16. Lacombe O., Woodley J., Solleux C., Delbos J.M., Boursier-Neyret C., Houin G. Localisation of drug permeability along the rat small intestine, using markers of the paracellular, transcellular and some transporter routes. Eur. J. Pharm. Sci. 2004, 23:385-391.
17. Lennernas H. Human intestinal permeability. J. Pharm. Sci. 1998, 87:403-410.
18. Norris D.A., Leesman G.D., Sinko P.J., Grass G.M. Development of predictive pharmacokinetic simulation models for drug discovery. J. Control. Release 2000, 65:55-62.
19. Varma M.V., Kapoor N., Sarkar M., Panchagnula R. Simultaneous determination of digoxin and permeability markers in rat in situ intestinal perfusion samples by RP-HPLC. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2004, 813:347-352.
20. Venkatesh G., Ramanathan S., Nair N.K., Mansor S.M., Sattar M.A., Khan M.A., Navaratnam V. Permeability of atenolol and propranolol in the presence of dimethyl sulfoxide in rat single-pass intestinal perfusion assay with liquid chromatography/UV detection. Biomed. Chromatogr. 2007, 21:484-490.
21. Zakeri-Milani P., Barzegar-Jalali M., Tajerzadeh H., Azarmi Y., Valizadeh H. Simultaneous determination of naproxen, ketoprofen and phenol red in samples from rat intestinal permeability studies: HPLC method development and validation. J. Pharm. Biomed. Anal. 2005, 39:624-630.
22. Yee S. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth. Pharm. Res. 1997, 14:763-766.